Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Pereira, Cândida F ^a,b   Ellenberg, Paula C ^a,b   Jones, Kate L ^a   Fernandez, Tara L ^a,e   Smyth, Redmond P ^a,c   Hawkes, David J ^a   Hijnen, Marcel ^a,b   Vivet Boudou, Valérie ^c   Marquet, Roland ^c   Johnson, Iain ^d   Mak, Johnson ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Life Technologies   (United States)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIARSENICAL DYE; CAPSID PROTEIN; CYSTEINE; DYE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; INTEGRASE; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; PROTEINASE; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; TETRACYSTEINE; UNCLASSIFIED DRUG; ORGANOARSENIC DERIVATIVE; VIRUS PROTEIN;

ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS MUTANT; AMINO ACID SEQUENCE; CELL STRAIN HEK293; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PROTEIN CONFORMATION; PROTEIN MOTIF; STAINING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ARSENICALS; CYSTEINE; HEK293 CELLS; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; STAINING AND LABELING; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

EID: 79951831625     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017016     Document Type: Article

References (31)

1. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, et al. (2002) Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159: 441-452.
2. Das SC, Nayak D, Zhou Y, Pattnaik AK, (2006) Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J Virol 80: 6368-6377.
3. Campbell EM, Hope TJ, (2008) Live cell imaging of the HIV-1 life cycle. Trends Microbiol 16: 580-587.
4. Muller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, et al. (2004) Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol 78: 10803-10813.
5. Das SC, Panda D, Nayak D, Pattnaik AK, (2009) Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol 83: 2611-2622.
6. Panchal RG, Ruthel G, Kenny TA, Kallstrom GH, Lane D, et al. (2003) In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci USA 100: 15936-15941.
7. Lanman J, Crum J, Deerinck TJ, Gaietta GM, Schneemann A, et al. (2008) Visualizing flock house virus infection in Drosophila cells with correlated fluorescence and electron microscopy. J Struct Biol 161: 439-446.
8. Griffin BA, Adams SR, Tsien RY, (1998) Specific covalent labeling of recombinant protein molecules inside live cells. Science 281: 269-272.
9. Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, et al. (2002) New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc 124: 6063-6076.
10. Martin BR, Giepmans BN, Adams SR, Tsien RY, (2005) Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. Nat Biotechnol 23: 1308-1314.
11. Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, et al. (2008) Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog 4: e1000015.
12. Turville SG, Aravantinou M, Stossel H, Romani N, Robbiani M, (2008) Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat Methods 5: 75-85.
13. Arhel N, Genovesio A, Kim KA, Miko S, Perret E, et al. (2006) Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods 3: 817-824.
14. Mire CE, Dube D, Delos SE, White JM, Whitt MA, (2009) Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J Virol 83: 12139-12150.
15. Campbell EM, Perez O, Anderson JL, Hope TJ, (2008) Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J Cell Biol 180: 549-561.
16. Li Y, Lu X, Li J, Berube N, Giest KL, et al. (2010) Genetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells. J Virol 84: 7204-7213.
17. Hearps AC, Pryor MJ, Kuusisto HV, Rawlinson SM, Piller SC, et al. (2007) The biarsenical dye Lumio exhibits a reduced ability to specifically detect tetracysteine-containing proteins within live cells. J Fluoresc 17: 593-597.
18. Stroffekova K, Proenza C, Beam KG, (2001) The protein-labeling reagent FLASH-EDT2 binds not only to CCXXCC motifs but also non-specifically to endogenous cysteine-rich proteins. Pflugers Arch 442: 859-866.
19. Gaietta GM, Giepmans BN, Deerinck TJ, Smith WB, Ngan L, et al. (2006) Golgi twins in late mitosis revealed by genetically encoded tags for live cell imaging and correlated electron microscopy. Proc Natl Acad Sci U S A 103: 17777-17782.
20. Cavrois M, De NC, Greene WC, (2002) A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20: 1151-1154.
21. Hill MK, Hooker CW, Harrich D, Crowe SM, Mak J, (2001) Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1. J Virol 75: 6835-6840.
22. Sougrat R, Bartesaghi A, Lifson JD, Bennett AE, Bess JW, et al. (2007) Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog 3: e63.
23. Taguchi Y, Shi ZD, Ruddy B, Dorward DW, Greene L, et al. (2009) Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins. Mol Biol Cell 20: 233-244.
24. Abbondanzieri EA, Bokinsky G, Rausch JW, Zhang JX, Le Grice SF, et al. (2008) Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453: 184-189.
25. Liu S, Abbondanzieri EA, Rausch JW, Le Grice SF, Zhuang X, (2008) Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science 322: 1092-1097.
26. Harada S, Koyanagi Y, Yamamoto N, (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
27. Haertle T, Carrera CJ, Wasson DB, Sowers LC, Richman DD, et al. (1988) Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J Biol Chem 263: 5870-5875.
28. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291.
29. Hill MK, Shehu-Xhilaga M, Crowe SM, Mak J, (2002) Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J Virol 76: 11245-11253.
30. O'Doherty U, Swiggard WJ, Malim MH, (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74: 10074-10080.
31. Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ, (1995) Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 69: 4582-4586.